Market Place
Sourcing Support
Addressing Nitrosamine Risks in Pharmaceutical Manufacturing
10 Oct 2024 //
PRESS RELEASE
Rising Prevalence of Cancer and Its Impact on the HP API Market
10 Oct 2024 //
PRESS RELEASE
Polpharma`s HP API facility is live!
10 Oct 2024 //
PRESS RELEASE
Polpharma acquires Ziołolek
01 Oct 2024 //
PRESS RELEASE
Polpharma & MSN Lab Announce Strategic Distribution Partnership
23 Sep 2024 //
PRESS RELEASE
Polpharma’s strategic investment in HPAPI facility, the first of this kind in Poland
12 Sep 2024 //
PRESS RELEASE
NEUCA, Polpharma, Adamed, Teva, Zentiva Partner For ESG Development.
03 Sep 2024 //
PRESS RELEASE
First CADIFA certification from ANVISA for Etodolac
05 Mar 2024 //
PRESS RELEASE
Tackling N-Nitrosamines Challenge With High-Performance Instrumentation
28 Feb 2024 //
PRESS RELEASE
DKSH Has Successfully Entered Into a Strategic Partnership with Polpharma in Vietnam
15 Dec 2023 //
PRESS RELEASE
KiloLab Laboratory:strategic milestone achieved
11 Oct 2023 //
PRESS RELEASE
Ryvu Therapeutics And Polpharma Partner For RVU120 API Production For Phase II Trials
06 Jul 2023 //
PRESS RELEASE
Polpharma Makes Strategic Investment In Poland`s First HPAPI Manufacturing Facility
05 Jun 2023 //
PRESS RELEASE
Polpharma’s strategic investment in HPAPI facility
19 Apr 2023 //
CPHI ONLINE
Cryogenic infrastructure at API facility
31 Dec 2022 //
PRESS RELEASE
Liophilization: What does a strawberry have in common with Polpharma API?
21 Nov 2022 //
PRESS RELEASE
Polpharma’s strategic investment in HPAPI facility, the first of this kind in Poland
12 Oct 2022 //
PRESS RELEASE
Safe approach in delivering nitrosamine-free API products
10 Oct 2022 //
PRESS RELEASE
Polpharma partners with Pikralida biopharmaceutical start-up
19 Jul 2022 //
PRESS RELEASE
Polpharma Generic Dimethyl fumarate Receives Approval in Europe
17 Jun 2022 //
EMA
Farmaprojects becomes part of the Polpharma Group
12 Apr 2022 //
PCB
Polish Polpharma is cutting itself off from the Russian factory the owne is same
22 Mar 2022 //
GOSPODARKA
Poland’s largest pharma eyes Zentiva buyout: report
22 Jan 2022 //
FIERCEPHARMA
Polpharma Selects IQVIA`s Orchestrated Customer Engagement Platform
30 Sep 2021 //
BUSINESSWIRE
Searching for new, better, and innovative solutions. Digital at Polpharma API.
07 Sep 2021 //
PRESS RELEASE
September 2019 was the date when the transformation process started in the API Business Unit of Polpharma.
07 Sep 2021 //
PRESS RELEASE
Rapid Growth of Polish Biotech Sector Leads to Demand for Foreign Expertise
31 Aug 2021 //
BUSINESSWIRE
Poland’s Polpharma asks US court to grant Swiss arbitration in TS case
07 Aug 2021 //
LIFESCIENCESIPREVIEW
Bioeq has submitted a BLA to the FDA for the ranibizumab biosimilar
06 Aug 2021 //
BUSINESSWIRE
Polpharma & Bioeq Joint Venture Submission of Biosimilar Ranibizumab BLA to FDA
06 Aug 2021 //
BUSINESSWIRE
Polpharma in Warsaw Health Innovation Hub
14 Jun 2021 //
PRESS RELEASE
Polpharma awarded with Golden and Diamond CSR Leaves
11 Jun 2021 //
PRESS RELEASE
Merger of companies
01 Apr 2021 //
PRESS RELEASE
Polpharma Awarded In The Competition Family And Human Friendly Company
30 Mar 2021 //
PRESS RELEASE
Polpharma has received the 2020 Ethical Company title
24 Mar 2021 //
PRESS RELEASE
Polpharma at the top in the category of the exact sciences in the study “Most Attractive Employer Poland” 2020
04 Mar 2021 //
PRESS RELEASE
Polpharma’s Office Certified as a “Building without Barriers”
10 Feb 2021 //
PRESS RELEASE
Polpharma Selects IQVIA’s Orchestrated Customer Engagement Platform
21 Jan 2021 //
MARTECHSERIES
Polpharma joins the Climate Leadership programme
18 Jan 2021 //
PRESS RELEASE
The first Polish test to distinguish between COVID-19 and flu to be placed on the market
21 Dec 2020 //
PRESS RELEASE
Polpharma supported the development of first Polish genetic test detecting SARS-CoV-2
09 Nov 2020 //
PRESS RELEASE
Polpharma in the top five of Polish National Champions
20 Oct 2020 //
PRESS RELEASE
Why particles size is important in pharmaceutical industry? Is it really problematic?
10 Sep 2020 //
PRESS RELEASE
Polpharma gets ISO 20400 certificate
20 Aug 2020 //
PRESS RELEASE
The digital transformation pill at Polpharma
04 Aug 2020 //
PRESS RELEASE
Article: Polpharma’s Innovative Child is ready to harvest
24 Jul 2020 //
PRESS RELEASE
Polpharma B2B – Manufacturer Of Generic Drugs And Active Pharmaceutical
14 Jul 2020 //
PHARMACEUTICAL-SUPPLIERS
The letter of recommendation from Independent Pharmaceutical Quality Systems Consultant!
03 Jul 2020 //
PRESS RELEASE
On Demand Webinar: Looking to develop a high quality, high titer manufacturing cell line?
24 Jun 2020 //
PRESS RELEASE
Polpharma once again with the CSR Golden Leaf
12 Jun 2020 //
PRESS RELEASE
Polpharma again at the top of the Ranking of Responsible Companies
10 Jun 2020 //
PRESS RELEASE
Cyclobenzaprine Market (Impact Of Covid-19) Research Report 2020 Api Polpharma
05 May 2020 //
COLEOFDUTY
Polpharma is a Trustworthy Brand
04 May 2020 //
PRESS RELEASE
The first ventilators from Polpharma go to 22 hospitals in Poland
29 Apr 2020 //
PRESS RELEASE
All hands on deck! We all fight with COVID-19
17 Mar 2020 //
PRESS RELEASE
Coherus eyes ophthalmology biosimilars prize
03 Mar 2020 //
BIOPROCESSINTL
Article: Building an integrated biosimilars business
10 Feb 2020 //
PRESS RELEASE
Polpharma Group corporate social responsibility report 2017-2018
27 Dec 2019 //
PRESS RELEASE
